Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123827412 | 12382741 | 2 | F | 20160721 | 20160518 | 20160728 | EXP | GB-ROCHE-1717252 | GB-FRESENIUS KABI-FK201601238 | FRESENIUS KABI | 47.00 | YR | F | Y | 0.00000 | 20160728 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123827412 | 12382741 | 1 | PS | ONDANSETRON (MANUFACTURER UNKNOWN) | ONDANSETRON | 1 | Intravenous (not otherwise specified) | U | 76972 | 8 | MG | UNKNOWN | |||||||
| 123827412 | 12382741 | 2 | SS | IRINOTECAN (Manufacturer unknown) | IRINOTECAN | 1 | Intravenous (not otherwise specified) | U | 77776 | UNKNOWN | |||||||||
| 123827412 | 12382741 | 3 | SS | CAPECITABINE (Manufacturer unknown) | CAPECITABINE | 1 | Unknown | U | 0 | UNKNOWN | |||||||||
| 123827412 | 12382741 | 4 | SS | 5-FLUOROURACIL | FLUOROURACIL | 1 | 0 | ||||||||||||
| 123827412 | 12382741 | 5 | SS | ATROPINE. | ATROPINE | 1 | Subcutaneous | 0 | 250 | UG | |||||||||
| 123827412 | 12382741 | 6 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 0 | 350 | MG | |||||||||
| 123827412 | 12382741 | 7 | SS | DEXAMETHASON | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 0 | 6.6 | MG | |||||||||
| 123827412 | 12382741 | 8 | SS | EMEND | APREPITANT | 1 | Oral | 0 | 125 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123827412 | 12382741 | 1 | Product used for unknown indication |
| 123827412 | 12382741 | 2 | Product used for unknown indication |
| 123827412 | 12382741 | 3 | Product used for unknown indication |
| 123827412 | 12382741 | 4 | Product used for unknown indication |
| 123827412 | 12382741 | 5 | Product used for unknown indication |
| 123827412 | 12382741 | 6 | Product used for unknown indication |
| 123827412 | 12382741 | 7 | Product used for unknown indication |
| 123827412 | 12382741 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123827412 | 12382741 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123827412 | 12382741 | Anorectal disorder | |
| 123827412 | 12382741 | Diarrhoea | |
| 123827412 | 12382741 | Palmar-plantar erythrodysaesthesia syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |